Saudi Arabia To Mandate Economic Evaluation Studies For New Drugs From July 2025

 
• By Vibha Sharma

Companies marketing pharmaceutical products in Saudi Arabia are being urged to prepare for upcoming mandatory pharmacoeconomic assessments to demonstrate the added value of their drugs over existing treatments.

Close up of 3D medicine, tablets pills on top of Kingdom of Saudi Arabia money
The Saudi FDA is actively integrating pharmacoeconomic evaluation methods into its drug pricing decisions • Source: Shutterstock

More from Pink Sheet

More from Middle East & Africa